- Home
- NVNO vs DMA Comparison
NVNO vs DMA Comparison
Compare NVNO & DMA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NVNO
- DMA
- Stock Information
- Founded
- NVNO 1987
- DMA 2011
- Country
- NVNO United States
- DMA United States
- Employees
- NVNO N/A
- DMA N/A
- Industry
- NVNO Medical/Dental Instruments
- DMA Trusts Except Educational Religious and Charitable
- Sector
- NVNO Health Care
- DMA Finance
- Exchange
- NVNO Nasdaq
- DMA Nasdaq
- Market Cap
- NVNO 71.0M
- DMA 77.5M
- IPO Year
- NVNO N/A
- DMA N/A
- Fundamental
- Price
- NVNO $4.10
- DMA $8.80
- Analyst Decision
- NVNO
- DMA
- Analyst Count
- NVNO 0
- DMA 0
- Target Price
- NVNO N/A
- DMA N/A
- AVG Volume (30 Days)
- NVNO 145.2K
- DMA 34.6K
- Earning Date
- NVNO 07-30-2025
- DMA 01-01-0001
- Dividend Yield
- NVNO N/A
- DMA 2.04%
- EPS Growth
- NVNO N/A
- DMA N/A
- EPS
- NVNO N/A
- DMA N/A
- Revenue
- NVNO N/A
- DMA N/A
- Revenue This Year
- NVNO N/A
- DMA N/A
- Revenue Next Year
- NVNO N/A
- DMA N/A
- P/E Ratio
- NVNO N/A
- DMA N/A
- Revenue Growth
- NVNO N/A
- DMA N/A
- 52 Week Low
- NVNO $2.03
- DMA $4.78
- 52 Week High
- NVNO $6.48
- DMA $8.00
- Technical
- Relative Strength Index (RSI)
- NVNO 51.11
- DMA 51.55
- Support Level
- NVNO $3.90
- DMA $8.59
- Resistance Level
- NVNO $4.06
- DMA $8.80
- Average True Range (ATR)
- NVNO 0.26
- DMA 0.11
- MACD
- NVNO -0.06
- DMA -0.00
- Stochastic Oscillator
- NVNO 19.61
- DMA 62.07
About NVNO enVVeno Medical Corporation
enVVeno Medical Corp is a late clinical-stage medical device company focused on advancing bioprosthetic (tissue-based) solutions to improve the standard of care for treating venous disease. The company's product, VenoValve, is a surgical replacement venous valve that is currently being evaluated in a U.S. pivotal study. The company is also developing a second product called enVVe, which is a non-surgical, transcatheter-based replacement venous valve. Both the products are designed to act as one-way valves to help assist in propelling blood up the veins of the leg, and back to the heart and lungs. The company has determined that it currently operates in a single segment, Medical Device development, located in a single geographic location, the United States.
About DMA Destra Multi-Alternative Fund
Destra Multi-Alternative Fund is a non-diversified, closed-end management investment company that operates as an interval fund with a continuous offering of fund shares. The investment objective of the fund is to seek returns from capital appreciation and income with an emphasis on income generation.